Mainz Biomed (NASDAQ:MYNZ – Free Report) had its target price decreased by HC Wainwright from $5.00 to $3.00 in a research note published on Wednesday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Mainz Biomed’s Q4 2024 earnings at ($0.18) EPS and FY2024 earnings at […]
Mainz Biomed (NASDAQ:MYNZ – Free Report) had its price target cut by HC Wainwright from $5.00 to $3.00 in a research report report published on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Mainz Biomed’s Q4 2024 earnings at ($0.18) EPS and FY2024 earnings […]
Mainz Biomed (NASDAQ:MYNZ) and NanoViricides (NYSE:NNVC) Critical Comparison theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Mainz Biomed (NASDAQ:MYNZ – Free Report) had its target price reduced by HC Wainwright from $9.00 to $5.00 in a report issued on Monday morning, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Mainz Biomed’s Q4 2023 earnings at ($0.31) EPS, FY2023 earnings at ($1.67) […]
Mainz Biomed (NASDAQ:MYNZ – Free Report) – HC Wainwright upped their FY2023 earnings per share estimates for shares of Mainz Biomed in a report issued on Monday, November 20th. HC Wainwright analyst Y. Chen now anticipates that the company will earn ($1.67) per share for the year, up from their prior forecast of ($1.91). HC […]